Intratumoral Delivery of Chimeric Antigen Receptor-T Cells Targeting CD133 Effectively Treats Brain Metastases. Kieliszek AM, Mobilio D, Upreti D, Bloemberg D, et al. Clin Cancer Res 2023 Oct 3. doi: 10.1158/1078-0432.CCR-23-1735.

Read + Share

Amedeo Smart

Independent Medical Education

Kieliszek AM, Mobilio D, Upreti D, Bloemberg D, et al. Intratumoral Delivery of Chimeric Antigen Receptor-T Cells Targeting CD133 Effectively Treats Brain Metastases. Clin Cancer Res 2023 Oct 3. doi: 10.1158/1078-0432.CCR-23-1735.
PMID: 37787999